(See also Overview of Acid Secretion Overview of Acid Secretion Acid is secreted by parietal cells in the proximal two thirds (body) of the stomach. Gastric acid aids digestion by creating the optimal pH for pepsin and gastric lipase and by stimulating pancreatic... read more and Overview of Gastritis Overview of Gastritis Gastritis is inflammation of the gastric mucosa caused by any of several conditions, including infection (Helicobacter pylori), drugs (nonsteroidal anti-inflammatory drugs, alcohol), stress... read more .)
Patients with autoimmune metaplastic atrophic gastritis (AMAG) have antibodies to parietal cells and their components (which include intrinsic factor and the proton pump H+,K+-ATPase). AMAG is inherited as an autosomal dominant trait.
Some patients also develop Hashimoto thyroiditis Hashimoto Thyroiditis Hashimoto thyroiditis is chronic autoimmune inflammation of the thyroid with lymphocytic infiltration. Findings include painless thyroid enlargement and symptoms of hypothyroidism. Diagnosis... read more and 50% have thyroid antibodies; conversely, parietal cell antibodies are present in 30% of patients with thyroiditis.
In some patients, AMAG may be associated with chronic Helicobacter pylori infection Helicobacter pylori Infection Helicobacter pylori is a common gastric pathogen that causes gastritis, peptic ulcer disease, gastric adenocarcinoma, and low-grade gastric lymphoma. Infection may be asymptomatic or result... read more , although the relationship is not clear. Gastrectomy and chronic acid suppression with proton pump inhibitors cause similar deficiencies of intrinsic factor secretion.
Complications of AMAG include
The lack of intrinsic factor leads to vitamin B12 deficiency Vitamin B12 Deficiency Dietary vitamin B12 deficiency usually results from inadequate absorption, but deficiency can develop in vegans who do not take vitamin supplements. Deficiency causes megaloblastic anemia, damage... read more that can result in a megaloblastic anemia Megaloblastic Macrocytic Anemias Megaloblastic anemias result most often from deficiencies of vitamin B12 and folate. Ineffective hematopoiesis affects all cell lines but particularly red blood cells. Diagnosis is usually based... read more (pernicious anemia) or neurologic symptoms (subacute combined degeneration Symptoms and Signs Dietary vitamin B12 deficiency usually results from inadequate absorption, but deficiency can develop in vegans who do not take vitamin supplements. Deficiency causes megaloblastic anemia, damage... read more ).
The areas of atrophic gastritis in the body and fundus may manifest as metaplasia. Patients with AMAG have a 3-fold increased relative risk of developing gastric adenocarcinoma Stomach Cancer Etiology of stomach cancer is multifactorial, but Helicobacter pylori plays a significant role. Symptoms include early satiety, obstruction, and bleeding but tend to occur late in the disease... read more .
Patients with gland atrophy and/or intestinal metaplasia distributed multifocally, including to the lesser curvature of the corpus and fundus, have a phenotype called multifocal atrophic gastritis. Multifocal involvement is considered "extensive", in contrast to "marked," which refers to severity at a specific site. Risk of gastric adenocarcinoma is higher among patients who have multifocal atrophic gastritis.
Hypochlorhydria leads to G-cell hyperplasia and elevated serum gastrin levels (often > 1000 pg/mL [> 481 pmol/L]). Elevated gastrin levels lead to enterochromaffin-like cell hyperplasia, which occasionally undergoes transformation to a carcinoid tumor Overview of Carcinoid Tumors Carcinoid tumors develop from neuroendocrine cells in the gastrointestinal tract (90%), pancreas, pulmonary bronchi, and rarely the genitourinary tract. More than 95% of all gastrointestinal... read more .
Manifestations of autoimmune metaplastic atrophic gastritis (AMAG) itself are few and nonspecific, although some patients have upper abdominal discomfort.
Symptoms and signs of B12 deficiency Symptoms and Signs Dietary vitamin B12 deficiency usually results from inadequate absorption, but deficiency can develop in vegans who do not take vitamin supplements. Deficiency causes megaloblastic anemia, damage... read more may be minimal at first because anemia develops slowly, but eventually fatigue and weakness occur. Neurologic manifestations occur independently of the anemia but typically begin with decreased position and vibratory sensation in the extremities, accompanied by mild to moderate weakness and hyporeflexia.
There are no specific symptoms that point to this disorder. It is most often discovered when patients undergo endoscopy to evaluate upper abdominal discomfort or unexplained anemia. Endoscopic biopsy confirms the diagnosis. Serum B12 levels should be obtained. Parietal cell antibodies are usually present but are not measured routinely.
The American Gastroenterological Association's 2020 guidelines on management of gastric intestinal metaplasia recommend testing for and treating H. pylori in patients with gastric intestinal metaplasia. These US guidelines also recommend against routine surveillance endoscopy in patients with autoimmune metaplastic atrophic gastritis and gastric intestinal metaplasia. Patients with atrophic gastritis and gastric intestinal metaplasia who have an increased risk of gastric cancer may elect to undergo surveillance, but they should be made aware of the low value of surveillance and the potential adverse effects of repeated upper endoscopies. Factors that increase the risk of gastric cancer include
Routine short-interval (within 1 year) repeat endoscopy and biopsy is not recommended unless the baseline endoscopy was inadequate or showed high-risk histology or unless the patient is at increased risk of gastric cancer. Again, the decision to repeat the endoscopy within 1 year should be made after patients understand the low value of surveillance and the potential adverse effects of repeated upper endoscopies. Longer-interval (every 3 to 5 years) surveillance endoscopy among patients with incidentally detected gastric intestinal metaplasia may be reasonable if shared decision-making favors surveillance.
The European Society of Gastrointestinal Endoscopy, European Helicobacter and Microbiota Study Group, European Society of Pathology, and Sociedade Portuguesa de Endoscopia Digestiva's 2019 update of the guidelines on management of epithelial precancerous conditions and lesions in the stomach emphasizes the use of high-definition endoscopy with chromoendoscopy in endoscopic evaluation of these patients.
The following are some English-language resources that may be useful. Please note that THE MANUAL is not responsible for the content of these resources.
American Gastroenterological Association: 2020 Guidelines on management of gastric intestinal metaplasia
European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED): 2019 Guidelines for the management of precancerous conditions and lesions in the stomach (MAPS)